ESMO 临床实践指南关于慢性淋巴细胞白血病一线和复发新靶向治疗的中期更新。
关键词: BCL2 inhibitor BTK inhibitor chronic lymphocytic leukaemia guideline update ibrutinib–venetoclax time-limited targeted therapy
Mesh : Humans Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy Molecular Targeted Therapy / methods Neoplasm Recurrence, Local / drug therapy pathology
来 源: DOI:10.1016/j.annonc.2024.06.016